Original Literature | Model OverView |
---|---|
Publication
Title
PI3K and negative regulation of TLR signaling.
Affiliation
Department of Microbiology and Immunology, Keio University School of Medicine,35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan.
Abstract
Excessive immune responses are detrimental to the host and negative feedbackregulation is crucial for the maintenance of immune-system integrity. Recentstudies have shown that phosphoinositide 3-kinase (PI3K) is an endogenoussuppressor of interleukin-12 (IL-12) production triggered by Toll-like receptor(TLR) signaling and limits excessive Th1 polarization. Unlike IRAK-M (IL-1receptor-associated kinase-M) and SOCS-1 (suppressor of cytokine signaling-1)that are induced by TLR signaling and function during the second or continuousexposure to stimulation, PI3K functions at the early phase of TLR signaling andmodulates the magnitude of the primary activation. Thus, PI3K, IRAK-M and SOCS-1have unique roles in the gate-keeping system, preventing excessive innate immuneresponses.
PMID
12860525
|
Entity
p38
--
MO000000022
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m31
10
infinite
0
TRANSPATH | MO000000022 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m26
10
infinite
0
TRANSPATH | MO000000058 |
--
IL-12
--
MO000017265
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2121
10
infinite
0
TRANSPATH | MO000017265 |
--
PI3K family
--
MO000017608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2387
10
infinite
0
TRANSPATH | MO000017608 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
PI3K family
--
e11
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m11
10
infinite
0
TRANSPATH | MO000017608 |
--
peptidoglycan
--
e12
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
CD40L
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
CpG ODN
--
e14
cso30:c:Dna
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
LPS:TLR4:MyD88
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
LPS:TLR4:MyD88:IRAK
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
LPS:TLR4:MyD88:IRAK{p}
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
LPS:TLR4:MyD88:IRAK{p}:Tollip
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
LPS:TLR4:MyD88:IRAK{p}:Tollip:TRAF6
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TAK1{active}
--
e20
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m20
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
TLR2 ligand
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
TLR2 ligand: TLR2
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
LPS:TLR4:MYD88:PI3K
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
NF-kappaB{active}
--
e26
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000000058 |
--
MAP3K
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
MAP3K{active}
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
p38{active}
--
e30
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000022 |
--
ASK1{p}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
RelA-p65
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
IkappaB-alpha:NF-kappaB
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
IkappaB-alpha{p}:NF-kappaB
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
NF-kappaB{active}
--
e38
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m40
10
infinite
0
TRANSPATH | MO000000058 |
--
IL-12p40
--
e39
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
LPS:TLR4
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IL-12
--
e6
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 12860525, 7612223, 10973276 Stimulation through TLRs by PAMPs, such as lipopolysaccharide (LPS) (endotoxin), triggers production of various cytokines, including interleukin-12 (IL-12), which is a crucial inducer of Th1 responses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c29 : 1
stoichiometry:c28 : 1
m6*m14*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m1572*m5*0.1
nodelay
--
0
PMID: 12860525, 16924467, 12524386 PI3K is activated after triggering of many TLR members, suggesting the presence of ¡Æshared¡Ç signaling pathway(s) for TLR-mediated activation of PI3K. MyD88, TOLLIP (Toll-interacting protein), IRAK and TRAF6 [tumor necrosis factor (TNF) receptor-associated factor 6] are involved in such ¡Æshared¡Ç signaling pathway(s).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m184*m15*0.1
nodelay
--
0
PMID: 12860525, 16924467, 12524386 PI3K is activated after triggering of many TLR members, suggesting the presence of ¡Æshared¡Ç signaling pathway(s) for TLR-mediated activation of PI3K. MyD88, TOLLIP (Toll-interacting protein), IRAK and TRAF6 [tumor necrosis factor (TNF) receptor-associated factor 6] are involved in such ¡Æshared¡Ç signaling pathway(s).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m16*0.1
nodelay
--
0
PMID: 12860525, 16924467, 12524386 PI3K is activated after triggering of many TLR members, suggesting the presence of ¡Æshared¡Ç signaling pathway(s) for TLR-mediated activation of PI3K. MyD88, TOLLIP (Toll-interacting protein), IRAK and TRAF6 [tumor necrosis factor (TNF) receptor-associated factor 6] are involved in such ¡Æshared¡Ç signaling pathway(s).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m17*m3973*0.1
nodelay
--
0
PMID: 12860525, 16924467, 12524386 PI3K is activated after triggering of many TLR members, suggesting the presence of ¡Æshared¡Ç signaling pathway(s) for TLR-mediated activation of PI3K. MyD88, TOLLIP (Toll-interacting protein), IRAK and TRAF6 [tumor necrosis factor (TNF) receptor-associated factor 6] are involved in such ¡Æshared¡Ç signaling pathway(s).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m18*m183*0.1
nodelay
--
0
PMID: 12860525, 16924467, 12524386 PI3K is activated after triggering of many TLR members, suggesting the presence of ¡Æshared¡Ç signaling pathway(s) for TLR-mediated activation of PI3K. MyD88, TOLLIP (Toll-interacting protein), IRAK and TRAF6 [tumor necrosis factor (TNF) receptor-associated factor 6] are involved in such ¡Æshared¡Ç signaling pathway(s).
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c46 : 1
stoichiometry:c45 : 1
m1573*m19*0.1
nodelay
--
0
PMID: 12860525, 11129660, 11460167 In TLR4 signaling, TAK1 (transforming growth factor ¦Â-activated kinase 1) and TRAF6 pathways are operative in PI3K activation downstream of TLR4.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c49 : 1
stoichiometry:c48 : 1
m2387*m20*0.1
nodelay
--
0
PMID: 12860525, 11129660, 11460167 In TLR4 signaling, TAK1 (transforming growth factor ¦Â-activated kinase 1) and TRAF6 pathways are operative in PI3K activation downstream of TLR4.
p18
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c52 : 1
stoichiometry:c51 : 1
m207*m20*0.1
nodelay
--
0
PMID: 12860525 confirmed pathway from fig.1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m22*m3964*0.1
nodelay
--
0
PMID: 12860525 TLR2 binds TLR2 ligand
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c4 : 1
m5*0.1
nodelay
--
0
PMID: 12860525, 7612223, 10973276 Stimulation through TLRs by PAMPs, such as lipopolysaccharide (LPS) (endotoxin), triggers production of various cytokines, including interleukin-12 (IL-12), which is a crucial inducer of Th1 responses.
p20
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c58 : 1
stoichiometry:c57 : 1
m146*m23*0.1
nodelay
--
0
PMID: 12860525, 11101877 activation of PI3K downstream of TLR2 is mediated in a Rac1-dependent manner.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c61 : 1
stoichiometry:c60 : 1
m2387*m24*0.1
nodelay
--
0
PMID: 12860525, 11101877 activation of PI3K downstream of TLR2 is mediated in a Rac1-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m15*m2387*0.1
nodelay
--
0
PMID: 12860525, 12616480 interaction of PI3K with MyD88 in response to LPS has been reported, demonstrating the importance of such ¡Æshared¡Ç signaling in the PI3K pathway
p23
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c67 : 1
stoichiometry:c66 : 1
m26*m21*0.1
nodelay
--
0
PMID: 12860525 confirmed pathway from fig.1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m28*m20*0.1
nodelay
--
0
--
p25
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c89 : 1
stoichiometry:c72 : 1
m1875*m29*0.1
nodelay
--
0
PMID: 12860525 confirmed pathway from fig.1 PMID: 12860525, 11154276 Protein kinase B (PKB)-mediated phosphorylation of apoptosis signal-regulating kinase 1 (ASK1), one of the MAPK kinase kinases (MAPKK-Ks), blocks ASK1 kinase activity, leading to suppression of MAPK kinase 3 (MKK3) or MKK6, upstream regulators of p38
p26
p26
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c82 : 1
stoichiometry:c78 : 1
m31*m33*0.1
nodelay
--
0
PMID: 12860525 confirmed pathway from fig.1
p27
p27
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c88 : 1
stoichiometry:c87 : 1
m71*m34*0.1
nodelay
--
0
PMID: 12860525, 11154276 Protein kinase B (PKB)-mediated phosphorylation of apoptosis signal-regulating kinase 1 (ASK1), one of the MAPK kinase kinases (MAPKK-Ks), blocks ASK1 kinase activity, leading to suppression of MAPK kinase 3 (MKK3) or MKK6, upstream regulators of p38
p28
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c90 : 1
stoichiometry:c80 : 1
m3613*m29*0.1
nodelay
--
0
PMID: 12860525, 11154276 Protein kinase B (PKB)-mediated phosphorylation of apoptosis signal-regulating kinase 1 (ASK1), one of the MAPK kinase kinases (MAPKK-Ks), blocks ASK1 kinase activity, leading to suppression of MAPK kinase 3 (MKK3) or MKK6, upstream regulators of p38
p29
p29
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m45*m11*0.1
nodelay
--
0
PMID: 12860525, 9192891 activation of PKB is positively regulated by PI3K.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c8 : 1
stoichiometry:c6 : 1
m6*m5*0.1
nodelay
--
0
PMID: 12860525, 7612223, 10973276 Stimulation through TLRs by PAMPs, such as lipopolysaccharide (LPS) (endotoxin), triggers production of various cytokines, including interleukin-12 (IL-12), which is a crucial inducer of Th1 responses.
p30
p30
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c75 : 1
m31*m30*0.1
nodelay
--
0
PMID: 12860525 confirmed pathway from fig.1
p31
p31
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c97 : 1
stoichiometry:c93 : 1
m166*m11*0.1
nodelay
--
0
PMID: 12860525, 11101877, 10373529 NF-¦ÊB transactivation by the PI3K cascade in TLR2-mediated signaling is independent of I¦ÊB¦Á (inhibitor of NF-¦ÊB¦Á) degradation and triggered by PI3K-pathway-mediated p65 phosphorylation.
p32
p32
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c96 : 1
stoichiometry:c91 : 1
stoichiometry:c95 : 1
m31*m36*0.1
nodelay
--
0
PMID: 12860525, 11387313 PKB blocks kinase activity of MEKK3, another MAPKK-K upstream of p38.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c100 : 1
stoichiometry:c106 : 1
stoichiometry:c99 : 1
m38*m21*0.1
nodelay
--
0
PMID: 12860525, 12052830 inhibition of PI3K augments the phosphorylation and degradation of I¦ÊB¦Á, resulting in nuclear localization of NF-¦ÊB in monocytes.
p34
p34
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c107 : 1
stoichiometry:c101 : 1
stoichiometry:c103 : 1
m39*0.1
nodelay
--
0
PMID: 12860525, 12052830 inhibition of PI3K augments the phosphorylation and degradation of I¦ÊB¦Á, resulting in nuclear localization of NF-¦ÊB in monocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c108 : 1
stoichiometry:c105 : 1
m27*0.1
nodelay
--
0
PMID: 12860525, 12052830 inhibition of PI3K augments the phosphorylation and degradation of I¦ÊB¦Á, resulting in nuclear localization of NF-¦ÊB in monocytes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c109 : 1
m40*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c110 : 1
m40*0.1
nodelay
--
0
PMID: 12860525, 7612223, 10973276 NF-¦ÊB activation is required for the transcription of both IL-12 p35 and p40
p4
p4
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c11 : 1
stoichiometry:c10 : 1
m2387*m12*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
p5
p5
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m13*m2387*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
p6
p6
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c17 : 1
stoichiometry:c16 : 1
m2387*m14*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
p7
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c20 : 1
stoichiometry:c19 : 1
m2387*m3373*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
p8
p8
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c23 : 1
stoichiometry:c22 : 1
m6*m3373*0.1
nodelay
--
0
PMID: 12860525, 12154357, 11101877, 9195953, 10635328, 7507510, 11509631 PI3Ks are activated in DCs by many distinct stimuli, including LPS, peptidoglycan, CpG-oligodeoxynucleotide (CpG-ODN), CD40L and RANKL (receptor activator of NF-¦ÊB ligand), all of which induce IL-12 production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c26 : 1
stoichiometry:c25 : 1
m6*m13*0.1
nodelay
--
0
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--